Skip to content

Clinical trials

Proteinuria trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Proteinuria Country / region: South Korea Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20112
20121
20142
20182
20201
20212
20223
20231
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting6
Unknown status3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Alexion Pharmaceuticals, Inc.3
Seoul National University Hospital3
Bayer2
Ajou University School of Medicine1
Astellas Pharma Korea, Inc.1
Boryung Pharmaceutical Co., Ltd1
Jade Biosciences, Inc.1
Kyungpook National University Hospital1
Omeros Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Proteinuria21
Glomerulonephritis, IGA9
Renal Insufficiency, Chronic7
Autoimmune Diseases2
Diabetic Nephropathies2
Glomerulonephritis2
Glomerulonephritis, Membranoproliferative2
Immune System Diseases2
Kidney Diseases2
Lupus Nephritis2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.